Department of Pharmacognosy, Dr. Baba Saheb Ambedkar Technological University of Lonere, Maharashtra, India
Mini Review
Pharmacovigilance Safety Monitoring in Clinical Trails
Author(s): Yashwant D. Nakhate*, Mohammed Tauqeer Sheikh, Kanchan S. Talekar and Sapana Tadas
Monitoring patient safety during clinical trials is a critical component throughout the drug development life-cycle.
Pharmaceutical sponsors must work proactively and collaboratively with all stakeholders to ensure a systematic
approach to safety monitoring. The regulatory landscape has evolved with increased requirements for risk management
plans, risk evaluation and minimization strategies. As the industry transitions from passive to active safety surveillance
activities, there will be greater demand for more comprehensive and innovative approaches that apply quantitative
methods to accumulating data from all sources, ranging from the discovery and preclinical through clinical and
post-approval stages. Statistical methods, especially those based on the Bayesian framework, are important tools to
help provide objectivity and rigor to the safety monitoring process... View more»